TP53 and cancer: We also showed that Mycoplasma DnaK, co-immunoprecipitates with USP10, a key p53 regulator, thus impairing p53-dependent anti-cancer functions, resulting in reduced efficacy of anti-cancer drugs that depend on p53 activation to exert their effect [180].